How one university overcame practical and cultural challenges to implement CDISC compliance
A US-based university with a nationally recognized academic health center implemented Clinical Data Interchange Standards…
CertaraMay 8, 2024
CERTAINTY – Japan
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
CertaraMay 7, 2024
CERTAINTY – South Korea
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
CertaraMay 7, 2024
Certara Reports First Quarter 2024 Financial Result
Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. (Nasdaq: CERT), a…
CertaraMay 7, 2024
Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future
The article "Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future" by Karen Rowland…
CertaraMay 6, 2024
Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model
The rapid growth in the use of pediatric physiologically based pharmacokinetic (PBPK) models, particularly for…
CertaraMay 6, 2024
How Chinese CRO, Zhejiang Longcharm Biomedical Technology Uses Pinnacle 21 Enterprise to Optimize Sponsors’ Non-clinical and Clinical Regulatory Affairs
Learn how one CRO uses Pinnacle 21 to optimize sponsors’ clinical regulatory affairs, saving time…
CertaraMay 6, 2024
RAPS Sponsored Webcast: Regulatory & Tech Advances in Drug Safety Reporting
Meeting the escalating global demand for new medications requires expediting regulatory submission development. Documenting drug…
CertaraMay 3, 2024
